Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds
Novo Nordisk's study shows liraglutide can effectively reduce BMI in children aged 6-12, yet it raises concerns about long-term safety and developmental impact.
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk's decision to halt production of insulin pens raises ethical concerns over prioritizing profits from weight-loss drugs over patients' health.
Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms
CagriSema failed to meet weight loss expectations in trials, causing significant stock decline for Novo Nordisk.
Wegovy Approved to Cut Heart Disease and Stroke Risk
Weight loss drugs approved for heart health benefits
Semaglutide linked to cardiovascular risk reduction
Novo Nordisk's record-breaking growth highlights 'insatiable demand' for weight loss drugs
Novo Nordisk achieved a 20-year high in revenue growth rate, beating estimates for FY2023 revenue and earnings.
The growth is not demand constrained but production capacity constrained, with an insatiable demand for weight loss drugs.
Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds
Novo Nordisk's study shows liraglutide can effectively reduce BMI in children aged 6-12, yet it raises concerns about long-term safety and developmental impact.
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk's decision to halt production of insulin pens raises ethical concerns over prioritizing profits from weight-loss drugs over patients' health.
Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms
CagriSema failed to meet weight loss expectations in trials, causing significant stock decline for Novo Nordisk.
Wegovy Approved to Cut Heart Disease and Stroke Risk
Weight loss drugs approved for heart health benefits
Semaglutide linked to cardiovascular risk reduction
Novo Nordisk's record-breaking growth highlights 'insatiable demand' for weight loss drugs
Novo Nordisk achieved a 20-year high in revenue growth rate, beating estimates for FY2023 revenue and earnings.
The growth is not demand constrained but production capacity constrained, with an insatiable demand for weight loss drugs.
US obesity rates drop for 1st time in a decade, with possible help from weight loss medications
Obesity rates in the U.S. showed a slight decline from 46% to 45.6%, marking the first decrease in over a decade.
Science in 2025: the events to watch for next year
Emerging obesity treatments like orforglipron and retatrutide show significant potential, possibly transforming the landscape of weight loss drugs in 2025.
Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled
Teenagers are increasingly being prescribed semaglutide drugs, raising concerns about long-term health impacts.
How will weight-loss drugs change our relationship with food?
Weight-loss drugs are reshaping the conversation around obesity, challenging moral stigmas and impacting societal attitudes toward health and personal responsibility.
Ozempic is about to get a lot cheaper. If Trump can agree to a Biden-era idea:
The Biden administration proposes covering weight-loss injectables under Medicare and Medicaid, potentially aiding millions of obese Americans.
Biden proposes Medicare and Medicaid cover weight-loss drugs for 7.4m people
The Biden administration aims to provide free weight loss drugs to low-income individuals and retirees to combat obesity.
US obesity rates drop for 1st time in a decade, with possible help from weight loss medications
Obesity rates in the U.S. showed a slight decline from 46% to 45.6%, marking the first decrease in over a decade.
Science in 2025: the events to watch for next year
Emerging obesity treatments like orforglipron and retatrutide show significant potential, possibly transforming the landscape of weight loss drugs in 2025.
Teenagers Are Taking New Weight-Loss Drugs, but the Science Is Far from Settled
Teenagers are increasingly being prescribed semaglutide drugs, raising concerns about long-term health impacts.
How will weight-loss drugs change our relationship with food?
Weight-loss drugs are reshaping the conversation around obesity, challenging moral stigmas and impacting societal attitudes toward health and personal responsibility.
Ozempic is about to get a lot cheaper. If Trump can agree to a Biden-era idea:
The Biden administration proposes covering weight-loss injectables under Medicare and Medicaid, potentially aiding millions of obese Americans.
Biden proposes Medicare and Medicaid cover weight-loss drugs for 7.4m people
The Biden administration aims to provide free weight loss drugs to low-income individuals and retirees to combat obesity.
Weight Loss Drugs Changed Their Lives. Then They Lost Coverage.
Blue Cross Blue Shield of Michigan has limited coverage for weight-loss drugs, impacting thousands who rely on them for health and well-being.
Thinking of buying Wegovy online. Here's what to know about compounding pharmacies
Compounded weight-loss drugs can offer a more affordable option compared to brand-name medications like Wegovy, potentially benefiting those struggling with insurance coverage and high costs.
Weight Loss Drugs Changed Their Lives. Then They Lost Coverage.
Blue Cross Blue Shield of Michigan has limited coverage for weight-loss drugs, impacting thousands who rely on them for health and well-being.
Thinking of buying Wegovy online. Here's what to know about compounding pharmacies
Compounded weight-loss drugs can offer a more affordable option compared to brand-name medications like Wegovy, potentially benefiting those struggling with insurance coverage and high costs.
Ozempic may help battle drug and alcohol addiction
Weight-loss drugs Ozempic and Mounjaro may help reduce substance abuse cravings and binging, showing protective effects on overdose and binge drinking rates.
Could Ozempic treat addiction?
GLP-1 receptor agonists may reduce cravings not just for food but also for drugs and alcohol, aiding recovery from addiction.
Ozempic may help battle drug and alcohol addiction
Weight-loss drugs Ozempic and Mounjaro may help reduce substance abuse cravings and binging, showing protective effects on overdose and binge drinking rates.
Could Ozempic treat addiction?
GLP-1 receptor agonists may reduce cravings not just for food but also for drugs and alcohol, aiding recovery from addiction.
Enormous potential': weight-loss drugs cut cancer risk by a fifth, research shows
Weight-loss drugs can reduce the risk of developing certain types of cancers and improve long-term survival rates.
Weight-loss drugs can improve kidney health, study finds
GLP-1 receptor agonists significantly lower the risk of kidney failure, worsening kidney function, and death due to kidney disease by approximately 19%.
Enormous potential': weight-loss drugs cut cancer risk by a fifth, research shows
Weight-loss drugs can reduce the risk of developing certain types of cancers and improve long-term survival rates.
Weight-loss drugs can improve kidney health, study finds
GLP-1 receptor agonists significantly lower the risk of kidney failure, worsening kidney function, and death due to kidney disease by approximately 19%.
Medicaid dominates coverage of Novo, Lilly weight-loss drugs
Government health plans overwhelmingly dominate coverage for weight-loss drugs, covering over 52 million Americans compared to about 24 million in private plans.
Vogue boss 'concerned' by return to skinny models
The fashion industry is shifting back to favoring skinny models, raising concerns about body diversity and the influence of weight-loss drugs like Ozempic.
Americans seeking Eli Lilly and Novo Nordisk's weight-loss drugs turn to compounded market
Patients are struggling to obtain weight-loss and diabetes medications due to supply issues and insurance problems, turning instead to cheaper online alternatives.
Drugmaker shut down after black schmutz found in injectable weight-loss drug
FDA warns about safety issues with compounded weight-loss drugs as pharmaceutical companies fight against them amid legal battles and differing interests.
Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in
Smaller competitors are preparing to enter the weight-loss drug market dominated by Eli Lilly and Novo Nordisk.
Americans seeking Eli Lilly and Novo Nordisk's weight-loss drugs turn to compounded market
Patients are struggling to obtain weight-loss and diabetes medications due to supply issues and insurance problems, turning instead to cheaper online alternatives.
Drugmaker shut down after black schmutz found in injectable weight-loss drug
FDA warns about safety issues with compounded weight-loss drugs as pharmaceutical companies fight against them amid legal battles and differing interests.
Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in
Smaller competitors are preparing to enter the weight-loss drug market dominated by Eli Lilly and Novo Nordisk.
The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclear
Consumers overdosing on knock-off semaglutide weight-loss drugs.
Ozempic may help manage opioid addiction: study
Semaglutide (Ozempic) significantly reduces the likelihood of opioid overdoses in patients with a history of opioid abuse, offering potential in addiction management.
Weight-loss drugs slow down the ageing process', scientists suggest
Weight-loss drugs like semaglutide may significantly enhance longevity and health by reducing overall mortality rates.
A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs
Genetic test MyPhenome can predict response to weight-loss drug semaglutide with 75% accuracy, categorizing people into four types of weight gain.
The FDA says patients may be overdosing on imitation semaglutide weight-loss drugs because the directions are unclear
Consumers overdosing on knock-off semaglutide weight-loss drugs.
Ozempic may help manage opioid addiction: study
Semaglutide (Ozempic) significantly reduces the likelihood of opioid overdoses in patients with a history of opioid abuse, offering potential in addiction management.
Weight-loss drugs slow down the ageing process', scientists suggest
Weight-loss drugs like semaglutide may significantly enhance longevity and health by reducing overall mortality rates.
A New Test Predicts Who Will Benefit Most from Weight-Loss Drugs
Genetic test MyPhenome can predict response to weight-loss drug semaglutide with 75% accuracy, categorizing people into four types of weight gain.
Weight loss drug market shows impressive growth, driven by GLP-1 agonists.
New potential applications for these drugs could significantly expand the market.
Positive investor sentiment around biotech companies focused on weight loss drugs.
Ozempic Gets the Oprah Treatment in a New TV Special
Weight-loss drugs like Ozempic, Wegovy, and Zepbound are becoming increasingly popular.
Oprah Winfrey's support for weight-loss medications in her ABC special may further boost the popularity of these drugs.
Obesity drugs aren't always forever. What happens when you quit?
GLP-1 agonists are popular weight-loss drugs, but many people discontinue due to cost, side effects, and other factors. Stopping these medications can lead to weight regain.
3 GLP-1 Stocks to Buy Now For Big Long-Term Gains
Weight loss drug market shows impressive growth, driven by GLP-1 agonists.
New potential applications for these drugs could significantly expand the market.
Positive investor sentiment around biotech companies focused on weight loss drugs.
Ozempic Gets the Oprah Treatment in a New TV Special
Weight-loss drugs like Ozempic, Wegovy, and Zepbound are becoming increasingly popular.
Oprah Winfrey's support for weight-loss medications in her ABC special may further boost the popularity of these drugs.
Obesity drugs aren't always forever. What happens when you quit?
GLP-1 agonists are popular weight-loss drugs, but many people discontinue due to cost, side effects, and other factors. Stopping these medications can lead to weight regain.
The next food marketing blitz is aimed at people on new weight-loss drugs
As new weight-loss drugs become popular, food manufacturers are adapting to cater to consumers on these medications.
Hims & Hers to sell inexpensive Ozempic alternative
Online pharmaceutical brands Hims & Hers are introducing a cost-effective weight-loss drug with semaglutide.
"Outrageously" priced weight-loss drugs could bankrupt US health care
The rise of effective weight-loss drugs could significantly impact America's high obesity rate and prescription drug pricing, potentially exerting a massive financial strain on the healthcare system.
Opinion | Oprah and America Embrace the Promise of Ozempic
The weight-loss industry is rebranding obesity as a disease, shifting blame from individuals to a medical condition.
Oprah's special focuses on her personal weight-loss journey and the use of drugs like Ozempic, highlighting the industry's shift towards medicalization.
Is Ozempic An Antidepressant? Preliminary Studies Suggest It Could Be
Weight loss drugs like Ozempic and Wegovy may have a positive impact on reducing depression and anxiety.
Dulaglutide, a GLP-1 agonist similar to semaglutide, shows potential in reversing metabolic damage in the brain and alleviating depression and anxiety in mice.
Wegovy, Ozempic, and Mounjaro are weight loss and diabetes drugs that target regulatory pathways involved in obesity and diabetes.
The body produces natural versions of these drugs, known as incretin hormones, in the gut, and the trillions of gut microbes play a key role in regulating these hormones.
The drug shortages Floridians will face in 2024. Here's what you should know
Drug shortages continue to threaten access to necessary medications, including treatments for short-term and chronic illnesses.
ADHD medications, chemotherapy drugs, weight-loss drugs, and the antibiotic amoxicillin are among the categories experiencing shortages in 2024.
Drugmakers hiking prices for more than 700 medications, including Ozempic and Mounjaro
Pharmaceutical companies have increased prices for over 700 medications, including popular weight-loss drugs.
The average price increase at the start of the year was around 4.5%, slightly slower than previous years.
Weight-loss drug coverage tops unlimited PTO, remote work in benefits survey - The Business Journals
Coverage for weight-loss drugs is a highly desired employee benefit
Employees are willing to change jobs for access to coverage for weight-loss drugs
Weight-Loss Drugs Don't Cause Suicidal Thoughts, FDA Says
There is no evidence that popular weight-loss drugs cause suicidal thoughts
The FDA's preliminary analysis showed no clear relationship between adverse-event reports of suicidal thoughts and GLP-1s
Can Dieting Actually Lead to Long-Term Weight Loss?
Weight loss drugs like Wegovy and Zepbound have shown to be more effective than traditional dieting methods.
Short-term dieting can help most people lose a small amount of weight, but long-term success and weight maintenance are challenging.